Large cell neuroendocrine carcinoma
Reviewers: Rugvedita Parakh, M.D., HCG Oncology (see Reviewers page)
Revised: 3 July 2011, last major update June 2011
Copyright: (c) 2003-2011, PathologyOutlines.com, Inc.
● Rare, aggressive tumor similar to counterpart in lung
● Combination of histologic (neuroendocrine morphology and necrosis), cytologic (large cell size, abundant cytoplasm, nucleoli, coarse chromatin, high mitotic rate) and imuunohistochemical evidence of neuroendocrine origin
● Distinguished from atypical carcinoid tumor by necrosis and higher mitotic rate
● 32 year old man with aggressive tumor (Pathol Int 2006;56:688)
● 73 year old man with aggressive tumor (Mod Pathol 1998;11:1016)
● 82 year old man whose tumor had small adenocarcinoma component (Arch Pathol Lab Med 2002;126:1229)
● Patient with cutaneous metastases (Am J Dermatopathol 2009;31:166)
● Resembles lung counterpart (Int J Urol 2008;15:1080)
● Either pure or mixed
● Large polygonal cells with low nuclear to cytoplasmic ratio, coarse chromatin, frequent nucleoli, 10+ mitotic figures/10 HPF, multiple areas of necrosis
● TTF1, Leu7/CD57, NSE
● Variable synaptophysin and chromogranin (Am J Clin Pathol 2007;128:733)
● Atypical cells with rosettes and nuclear molding, fine or coarsely granular chromatin, hyperchromasia
● Average nuclear to cytoplasmic ratio is 1:1.4 (Acta Cytol 2010;54:303)
End of Bladder > Urothelial carcinoma-invasive > Large cell neuroendocrine carcinoma
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at [email protected] with any questions (click here for other contact information).